0
Encephalopathy Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Articles |  7 September 2010
Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis: A Cohort Study
Manuel Romero-Gómez, MD, PhD; María Jover, PhD; José A. Del Campo, PhD; et al.
Ann Intern Med. 2010;153(5):281-288. doi:10.7326/0003-4819-153-5-201009070-00002
Editorials |  7 September 2010
Hepatic Encephalopathy in Our Genes?
Jan Albrecht, PhD
Ann Intern Med. 2010;153(5):335-336. doi:10.7326/0003-4819-153-5-201009070-00008
Reviews |  20 March 2007
Narrative Review: Fabry Disease
Joe T.R. Clarke, MD, PhD
Ann Intern Med. 2007;146(6):425-433. doi:10.7326/0003-4819-146-6-200703200-00007
ACP Journal Club |  15 October 2013
Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy
Kris V. Kowdley, MD, FACP; Blaire E. Burman, MD
Ann Intern Med. 2013;159(8):JC8. doi:10.7326/0003-4819-159-8-201310150-02008
ACP Journal Club |  17 August 2010
Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis
Brian T. Story, MD; Kris V. Kowdley, MD, FACP
Ann Intern Med. 2010;153(4):JC2-8. doi:10.7326/0003-4819-153-4-201008170-02008
ACP Journal Club |  18 November 2008
Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy
Joe Alcorn, MD
Ann Intern Med. 2008;149(10):JC5-11. doi:10.7326/0003-4819-149-10-200811180-02011
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)